Clinical Trials Logo

Muscular Dystrophy, Duchenne clinical trials

View clinical trials related to Muscular Dystrophy, Duchenne.

Filter by:

NCT ID: NCT02295748 Completed - Clinical trials for Duchenne Muscular Dystrophy

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Start date: December 2014
Phase: Phase 1
Study type: Interventional

This is an open label, long-term extension study in approximately 24 male DMD subjects consisting of children (ages 4-12, inclusive) and adolescents (ages 13-16, inclusive) who participated in the MP-104-CL-005 PK study.

NCT ID: NCT02286947 Completed - Clinical trials for Muscular Dystrophy, Duchenne

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

Start date: November 2014
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to explore safety and tolerability of eteplirsen in participants with advanced stage Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.

NCT ID: NCT02255552 Completed - Clinical trials for Duchenne Muscular Dystrophy (DMD)

Study of Eteplirsen in DMD Patients

PROMOVI
Start date: November 17, 2014
Phase: Phase 3
Study type: Interventional

The main objective of this study is to provide evidence of efficacy of eteplirsen (AVI-4658) in Duchenne muscular dystrophy (DMD) patients that are amenable to skipping exon 51. Additional objectives include evaluation of safety, biomarkers and the long-term effects of eteplirsen up to 96 weeks, followed by a safety extension (not to exceed 48 weeks).

NCT ID: NCT02251600 Completed - Clinical trials for Duchenne Muscular Dystrophy

A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy

Start date: December 2014
Phase: Phase 1
Study type: Interventional

Study to characterize the single-state and steady-state dosing of oral deflazacort in pediatric and adolescents subjects.

NCT ID: NCT02246478 Completed - Clinical trials for Duchenne Muscular Dystrophy

A Study of TAS-205 for Duchenne Muscular Dystrophy

Start date: September 2014
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the safety and pharmacokinetic of TAS-205 in patients with Duchenne Muscular Dystrophy.

NCT ID: NCT02235844 Completed - Clinical trials for Duchenne's Muscular Dystrophy

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Start date: September 2014
Phase: Phase 1
Study type: Interventional

This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.

NCT ID: NCT02207283 Completed - Clinical trials for Becker Muscular Dystrophy

PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy

Start date: March 2012
Phase: Phase 4
Study type: Interventional

This study is intended to build on recent findings from our laboratory showing that a single dose of tadalafil (also known as Cialis) restored normal blood flow regulation in men with Becker muscular dystrophy. The investigators now wish to extend these findings by showing that the same dose of tadalafil will also prevent muscle injury and fatigue. Patients will take a single dose of tadalafil prior to exercising. Then doctors will measure whether the patients muscles receive more blood flow and are better protected during exercise.

NCT ID: NCT02195999 Completed - Clinical trials for Muscular Dystrophy, Duchenne

Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy

CPI
Start date: December 2013
Phase:
Study type: Observational

This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral skeletal muscle dysfunction can predict cardiopulmonary dysfunction. The central hypothesis is that non-invasive MRI measures of the heart, muscle, and peripheral skeletal muscles can sensitively predict future cardiopulmonary decline.

NCT ID: NCT02194725 Completed - Stress Clinical Trials

Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy

Start date: July 6, 2014
Phase:
Study type: Observational

Background: - Children with Duchenne/Becker Muscular Dystrophy (DBMD) slowly lose muscle function. They usually die at a young age. Some mothers adapt to the demands of caring for a child with this disease better than others. Studies show that a person s hope may positively affect how they cope and adapt. Researchers want to find out more about this. They want to develop ways to improve caregivers overall wellness. Objective: - To study the relationships between uncertainty, hope, and coping ability in mothers of children with DBMD. Eligibility: - Women in the United States 18 years and older. They must be biological mothers of a living child with DBMD and be able to answer a survey in English. Design: - This study is part of a larger study that examines the well-being of mothers with sons who have DBMD. - Participants will take a questionnaire. The questionnaire can be done on paper or on a computer. It will take 30 45 minutes to complete. - The questionnaire will include basic demographic questions about the participant and the child. There will also be questions about how the participant copes with the stress and uncertainty of DBMD. - For most of the questions, participants will rate their feelings on a scale. There will also be four open-ended questions.

NCT ID: NCT02168114 Completed - Clinical trials for Duchenne Muscular Dystrophy

Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine the potential of Optical Imaging techniques to detect muscle damage in boys with Duchenne Muscular Dystrophy and unaffected exercised muscle. Healthy subjects will undergo two different exercises in opposite forearms before any imaging techniques are performed. Boys with Duchenne Muscular Dystrophy will only undergo the imaging techniques without exercise.